AWM
NVS icon

Ariadne Wealth Management’s Novartis NVS Stock Holding History

Ariadne Wealth Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$812K Hold
5,319
– – 0.36% 63
2025
Q4 		$857K Sell
5,319
-371
-7% -$48.6K 0.35% 64
2025
Q3 		$751K Buy
5,690
+282
+5% +$34.4K 0.34% 67
2025
Q2 		$655K Sell
5,408
-104
-2% -$11.7K 0.31% 68
2025
Q1 		$599K Sell
5,512
-582
-10% -$62K 0.31% 73
2024
Q4 		$651K Buy
6,094
+727
+14% +$77.5K 0.3% 66
2024
Q3 		$575K Buy
+5,367
New +$609K 0.31% 60

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ariadne Wealth Management's NVS Position: Q1 2026 in Review

Ariadne Wealth Management held its Novartis (NVS) position steady in Q1 2026 at 5,319 shares worth $812K. The position accounts for 0.36% of the portfolio, ranked #63.

Ariadne Wealth Management first reported a position in NVS in Q3 2024 and has held it in 7 quarters since. The position peaked at $857K in Q4 2025. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Ariadne Wealth Management held 5,319 shares of Novartis worth $812K as of Q1 2026.
  • Ariadne Wealth Management left its Novartis share count unchanged in Q1 2026.
  • Novartis made up 0.36% of Ariadne Wealth Management's portfolio in Q1 2026, its #63 holding.
  • Ariadne Wealth Management first reported a position in Novartis in Q3 2024 and has held it in 7 quarters since.
  • Ariadne Wealth Management's Novartis position peaked at $857K in Q4 2025.
  • 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Ariadne Wealth Management's 13F filing for Q1 2026, filed 18 May 2026.